SII applies to Indian authorities for full market authorisation of Covishield
PTI, Dec 31, 2021, 1:38 PM IST
New Delhi: Serum Institute of India (SII) CEO Adar Poonawala on Friday said it has applied to Indian authorities for full market authorisation of Covishield, stating supplies of the COVID-19 vaccine have exceeded 125 crore doses.
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country.
”Supplies of the COVISHIELD vaccine in India, have exceeded 1.25 billion doses. The government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF (DCGI) and @MoHFW_INDIA for this permission,” Poonawala said in a tweet tagging the Central Drugs Standard Control Organisation (CDSCO) and Ministry of Health and Family Welfare.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Exposure to outdoor artificial light at night may increase risk of stroke, study finds
Group of oncologists launch free-of-cost second opinion helpline number for cancer patients
Dogs understand more than they let on, create mental images of known words: Study
Caution advised as diarrhoea cases rise with onset of summer
Bharat Biotech begins clinical trials of TB vaccine on adults in India
MUST WATCH
Latest Additions
What court said as it extended Kejriwal’s ED custody till April 1
ED wants AAP’s LS poll strategy details from Kejriwal’s phone: Atishi
Last 3 days I was in bed, I was on painkillers: Parag
Attempt made to impersonate top CISF official; case registered
Mukhtar Ansari was subjected to slow poisoning in jail: Son